ARTL - ARTELO BIOSCIENCES, INC.

QQQ $ 451.64 $ -1.08 (-0.24 %)

DIA $ 399.23 $ 0.11 (0.03 %)

SPY $ 528.86 $ -0.07 (-0.01 %)

TLT $ 91.42 $ -0.20 (-0.22 %)

GLD $ 223.02 $ 0.78 (0.35 %)

Previous Close

$ 1.36

Open

$ 1.31

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.31 - $ 1.31

52 Week Range

$ 1.15 - $ 2.98

Volume

1,969

Average Volume

Market Cap

4.39M

Beta (5Y Monthly)

$ 1.60

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	03-25-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	01-12-2022	11-30-2021	10-Q
11	11-29-2021	08-31-2021	10-K
12	07-12-2021	05-31-2021	10-Q
13	04-13-2021	02-28-2021	10-Q
14	01-14-2021	11-30-2020	10-Q
15	11-04-2020	08-31-2020	10-K
16	07-13-2020	05-31-2020	10-Q
17	04-13-2020	02-29-2020	10-Q
18	01-14-2020	11-30-2019	10-Q
19	11-25-2019	08-31-2019	10-K
20	07-15-2019	05-31-2019	10-Q
21	04-15-2019	02-28-2019	10-Q
22	01-14-2019	11-30-2018	10-Q
23	11-29-2018	08-31-2018	10-K
24	07-13-2018	05-31-2018	10-Q
25	04-16-2018	02-28-2018	10-Q
26	01-16-2018	11-30-2017	10-Q
27	11-29-2017	08-31-2017	10-K
28	07-21-2017	05-31-2017	10-Q
29	04-14-2017	02-28-2017	10-Q
30	01-10-2017	11-30-2016	10-Q
31	11-29-2016	08-31-2016	10-K
32	07-05-2016	05-31-2016	10-Q
33	04-01-2016	02-29-2016	10-Q
34	01-14-2016	11-30-2015	10-Q
35	12-11-2015	08-31-2015	10-K
36	07-15-2015	05-31-2015	10-Q
37	04-14-2015	02-28-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Arte...
05/15/2024 11:16:58

HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...

Artelo Biosciences Q1 EPS $(0.78) Beats $(...
05/13/2024 12:18:35

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(...

Artelo Biosciences Reports Publication Pee...
04/23/2024 12:37:37

HC Wainwright & Co. Maintains Buy on Artel...
04/02/2024 15:42:00

HC Wainwright & Co. analyst Vernon Bernardino maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pri...

Artelo Biosciences Earlier Reported Q4 EPS...
03/25/2024 20:29:14

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of ...

Recap: Artelo Biosciences Q4 Earnings
03/25/2024 13:20:07

Artelo Biosciences FY23 EPS $(3.14) Vs $(3...
03/25/2024 12:20:41

Fiscal 2023 Year-End Financial ResultsCash and Investments: Cash and investments totalled $10.4 million as of December 31, 2023...

Artelo Biosciences Has Been Granted Europe...
03/20/2024 16:06:17

https://register.epo.org/application?number=EP18887462

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/06/2024 21:31:05

Artelo Biosciences Announces Publication O...
01/23/2024 13:32:31

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways...

Artelo Biosciences Announces Selection Of ...
01/08/2024 13:47:31

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways...

Artelo Biosciences Filed U.S. Patent Appli...
12/21/2023 12:22:41

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20230404939

Artelo Biosciences Presents New Preclinica...
12/05/2023 13:36:31

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways ...

Artelo Biosciences To Present Important Ne...
11/30/2023 14:01:50

HC Wainwright & Co. Reiterates Buy on Arte...
11/14/2023 11:46:50

HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...

Artelo Biosciences Q3 EPS $(0.83) Misses $...
11/13/2023 13:29:59

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of ...

Recap: Artelo Biosciences Q3 Earnings
11/13/2023 13:25:06

Artelo Biosciences Announces Publication O...
11/09/2023 14:23:25

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways ...

Artelo Biosciences To Present Preclinical ...
11/02/2023 12:54:19

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways ...

12 Health Care Stocks Moving In Wednesday'...
11/01/2023 21:31:27